Extrawell Pharmaceutical Holdings Limited (HKG:0858)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0770
-0.0010 (-1.28%)
At close: Mar 10, 2026
54.00%
Market Cap 198.90M
Revenue (ttm) 52.65M
Net Income (ttm) -338.02M
Shares Out 2.55B
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,310,000
Average Volume 3,087,000
Open 0.0780
Previous Close 0.0780
Day's Range 0.0750 - 0.0780
52-Week Range 0.0410 - 0.1490
Beta -0.12
RSI 43.15
Earnings Date Mar 13, 2026

About HKG:0858

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic of China and Hong Kong. The company manufactures transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound he... [Read more]

Sector Healthcare
Founded 1998
Employees 161
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0858
Full Company Profile

Financial Performance

Financial Statements

News

Extrawell Pharmaceutical CEO Xie Yi To Resign, Guo Yi To Be New CEO

(RTTNews) - Extrawell Pharmaceutical Holdings Limited (0858.HK), Tuesday announced that its Chief Executive Officer Dr. Xie Yi will resign from the position to focus on developing strategies for the c...

2 months ago - Nasdaq